Pharmacokinetics of oxiracetam following intravenous and oral administration in healthy volunteers
- 1 July 1984
- journal article
- research article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 9 (3) , 267-274
- https://doi.org/10.1007/bf03189650
Abstract
The kinetics of oxiracetam after single intravenous and oral doses (2000 mg) were investigated in four healthy volunteers. Following intravenous administration, the decline in serum levels showed a prolonged, rapid phase followed by a delayed terminal phase. Mean residence times ranged from 3.9 to 6.5 h. Volumes of distribution ranged from 0.9 to 1.81 · kg−1, whereas clearance values ranged from 100 to 119 ml·.h−1· kg -1 More than 90% of the intravenous dose was recovered unchanged in the urine within 48 h. Oral administration resulted in peak levels within 1–2 h; thereafter, the decline in serum levels showed a pattern similar to that observed after the intravenous dose — almost 50% of the oral dose was excreted in the urine within 6 h. The absolute availability of oral oxiracetam was 75 ± 7%.This publication has 5 references indexed in Scilit:
- Disposition of pulse dose methylprednisolone in adult and paediatric patients with the nephrotic syndromeEuropean Journal of Clinical Pharmacology, 1982
- The effects of oxiracetam (ISF 2522) in patients with organic brain syndrome (a double‐blind controlled study with piracetam)Drug Development Research, 1982
- Noncompartmental Determination of the Steady‐State Volume of DistributionJournal of Pharmaceutical Sciences, 1979
- Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients.British Journal of Clinical Pharmacology, 1979
- Determination of Common Parameters of Iodothyronine Metabolism and Distribution in Man by Noncompartmental AnalysisJournal of Clinical Endocrinology & Metabolism, 1975